3 catalysts for Scottish Mortgage shares to rise in 2023

Scottish Mortgage shares had a dreadful year in 2022, dropping 46%. Can the FTSE 100 trust make a comeback with these catalysts this year?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Athlete preparing to run on start line in a lane numbered '2023'

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Last year was one to forget for investors in Scottish Mortgage Investment Trust (LSE: SMT). The share price tanked 46% as the market sold off high-growth stocks in favour of less riskier assets. It meant Scottish Mortgage shares ended 2022 among the worst performers in the FTSE 100.

However, I think there are three catalysts that could spark a rebound in 2023.

Interest rates

Over half of the Scottish mortgage portfolio is allocated to high-growth US stocks. Rising interest rates have had a disproportionate effect on the valuations of such companies.

That’s because growth stocks generally get hit harder than value stocks by rising interest rates because their (potential) cash flows are further into the future.

Due to persistent high inflation, many analysts expect the US Federal Reserve (Fed) to continue raising interest rates in the first half of this year. The benchmark rate today stands between 4.25% and 4.5%. While that’s a 15-year high, it’s actually around the long-term average.

However, there’s evidence that US inflation may have peaked. If that’s the case, this may lead the Fed to hold rates (or even reduce them slightly). This could cause a sharp rebound in many of the growth stocks held by Scottish Mortgage.


Currently, nearly 13% of the trust’s portfolio is made up of Chinese assets. However, the managers have said that said its investments in China will be decided by whether the companies are aligned with government policy objctives.

This follows a major crackdown since 2020 on domestic tech companies by the authorities in Beijing. In response to this, the trust has sold Alibaba and slashed its holding in Tencent.

Top 10 Holdings (as at 30th November)

Holdings Country % of total assets
1. Moderna USA9.9
2. ASMLEurope6.8
3. Tesla USA4.9
4. Illumina USA4.1
5. NorthvoltEurope 3.6
6. MercadoLibreLatin America 3.2
7. Space Exploration Technologies (SpaceX) USA3.2
8. MeituanChina3.1
9. KeringEurope3.0
10. AmazonUSA2.4

The table shows that only one of the current top 10 holdings is based in China (food delivery giant Meituan). Even so, Chinese stocks account for well over £1bn of assets. So collectively they remain important to the trust’s performance moving forward.

Some analysts now think that the worst of the regulatory crackdown in China may be over. This could make Chinese stocks more appealing, sending their share prices up and helping Scottish Mortgage in the process.

Moderna readouts

The final potential catalyst concerns Moderna, the trust’s largest holding. Co-manager Tom Slater has said: “Moderna has a technology platform that could fundamentally change healthcare over the next decade.”

The company uses messenger RNA to instruct the body’s cells to produce proteins that can prevent or fight disease. Data readouts from some of its active clinical trials are due this year. If any of these are positive, then the stock could get a big boost.

Of course, were the results to be underwhelming, then the stock could take a hit. However, Moderna recently reported positive data from its phase 2b study for a personalised cancer vaccine. The stock skyrocketed more than 20% after this news. Something similar could happen again.

I’ll be buying more shares this year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Ben McPoland has positions in ASML, Illumina, MercadoLibre, Moderna, Scottish Mortgage Investment Trust Plc, and Tesla. The Motley Fool UK has recommended ASML, Amazon.com, MercadoLibre, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 14% in 2024, what’s next for the Lloyds share price?

This Fool takes a closer look at what prompted the Lloyds share price to rise this year, and offers her…

Read more »

Investing Articles

5 FTSE 100 stocks to consider for a lifetime of passive income

I see lots of cheap dividend stocks in the FTSE 100 right now, but prices are starting to rise. Here's…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

3 growth stocks I’m desperate to buy as the FTSE 100 dips

Never waste a dip, says Harvey Jones. Three of his favourite growth stocks have fallen over the last month and…

Read more »

Investing Articles

I’d use a £10K ISA to try and generate £900 in dividends annually like this!

Christopher Ruane explains how he would invest a Stocks and Shares ISA in blue-chip companies to try and set up…

Read more »

Investing Articles

Here’s how I’d build a second income stream worth £1,228 a month by investing £10 a day!

A second income stream could come in handy later in life. This Fool explains how she’d build one by investing…

Read more »

Investing Articles

5 FTSE 250 stocks I’d buy for a lifetime of passive income

Here's why I think the FTSE 250 could be the best UK stock market index to go for in 2024…

Read more »

Union Jack flag triangular bunting hanging in a street
Investing Articles

Buy cheap FTSE shares, says HSBC

Analysts at HSBC have upgraded their rating of FTSE stocks and reckon the blue-chip UK index could carry on powering…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

It could be worth buying the dip for this FTSE 250 stock, down 7% today

Jon Smith spots a sharp drop in a FTSE 250 stock but explains why this could just be a blip…

Read more »